Freedom Capital Downgrades Viemed Healthcare (NASDAQ:VMD) to Hold

Viemed Healthcare (NASDAQ:VMD) was downgraded by equities research analysts at Freedom Capital from a “strong-buy” rating to a “hold” rating in a research report issued on Wednesday,Zacks.com reports.

Separately, Weiss Ratings upgraded Viemed Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Viemed Healthcare presently has a consensus rating of “Hold”.

Viemed Healthcare Stock Performance

Shares of NASDAQ VMD opened at $9.52 on Wednesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.13 and a quick ratio of 1.10. Viemed Healthcare has a one year low of $6.05 and a one year high of $12.61. The business’s 50-day moving average price is $11.15 and its two-hundred day moving average price is $9.75. The company has a market capitalization of $362.62 million, a P/E ratio of 26.45 and a beta of 1.10.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Monday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.05). The business had revenue of $78.10 million during the quarter, compared to analyst estimates of $78.00 million. Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. Analysts anticipate that Viemed Healthcare will post 0.44 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider William Frazier sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the sale, the insider directly owned 73,214 shares of the company’s stock, valued at $858,068.08. This represents a 12.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Timothy Smokoff sold 20,000 shares of Viemed Healthcare stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the completion of the sale, the director directly owned 75,518 shares of the company’s stock, valued at $868,457. This trade represents a 20.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 20.60% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. State of Alaska Department of Revenue bought a new position in Viemed Healthcare during the fourth quarter worth about $25,000. Kemnay Advisory Services Inc. bought a new stake in shares of Viemed Healthcare in the 4th quarter valued at about $46,000. Quarry LP bought a new stake in shares of Viemed Healthcare in the 3rd quarter valued at about $48,000. Diversified Trust Co bought a new stake in shares of Viemed Healthcare in the 1st quarter valued at about $107,000. Finally, Regent Peak Wealth Advisors LLC acquired a new stake in shares of Viemed Healthcare in the 2nd quarter valued at approximately $137,000. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.